# Amgen Inc: filings

AMGN · Nasdaq · CIK 318154 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amgn.md) · [Financials](/companies/amgn/financials.md) · [Filings](/companies/amgn/filings.md) · [Insiders](/companies/amgn/insiders.md)

## Reports and events: 319 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1424, 8-K 217, DEFA14A 67, 10-Q 53, SC 13G/A 53, 3 48, 11-K 36, FWP 31, CT ORDER 28, 144 25, S-8 POS 25, 424B3 21, SC TO-T/A 21, 424B2 19, 10-K 18, DEF 14A 18, SC 13G 16, CORRESP 14, UPLOAD 14, 5 13, SC TO-I/A 13, ARS 11, S-8 10, SC TO-C 8, S-3ASR 6, 3/A 5, 4/A 4, D/A 4, EFFECT 4, NO ACT 4, PX14A6G 4, SC 13D 4, SC 13D/A 4, SCHEDULE 13G/A 3, SC TO-T 3, 10-K/A 2, 10-Q/A 2, 25-NSE 2, 8-A12B 2, POS AM 2, PRE 14A 2, S-4 2, SCHEDULE 13G 2, SC TO-I 2, 144/A 1, 25 1, 8-K/A 1, CERT 1, CERTNYS 1, D 1, S-4/A 1, SD 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 17:58 ET | [8-K](/filings/0000318154-26-000144.md) | 5.02 Departure or appointment of officers or directors | 0000318154-26-000144 |
| 2026-08-05 | 18:29 ET | [10-Q](/filings/0000318154-26-000126.md) | Quarterly report, period 2026-06-30 | 0000318154-26-000126 |
| 2026-08-04 | 16:03 ET | [8-K](/filings/0000318154-26-000124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-26-000124 |
| 2026-07-31 | 16:03 ET | [8-K](/filings/0000318154-26-000119.md) | 1.05 Material cybersecurity incident | 0000318154-26-000119 |
| 2026-05-20 | 16:59 ET | [8-K](/filings/0001193125-26-232786.md) | 5.07 Shareholder vote results | 0001193125-26-232786 |
| 2026-05-19 | 16:08 ET | [8-K](/filings/0000318154-26-000097.md) | 5.02 Departure or appointment of officers or directors | 0000318154-26-000097 |
| 2026-05-01 | 19:04 ET | [10-Q](/filings/0000318154-26-000057.md) | Quarterly report, period 2026-03-31 | 0000318154-26-000057 |
| 2026-04-30 | 16:03 ET | [8-K](/filings/0000318154-26-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-26-000054 |
| 2026-04-22 | 16:03 ET | [8-K](/filings/0000318154-26-000048.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000318154-26-000048 |
| 2026-04-07 | 16:22 ET | [DEF 14A](/filings/0001193125-26-145588.md) | Proxy statement, period 2026-05-19 | 0001193125-26-145588 |
| 2026-02-19 | 16:27 ET | [8-K](/filings/0001193125-26-059490.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-059490 |
| 2026-02-13 | 16:07 ET | [10-K](/filings/0000318154-26-000010.md) | Annual report, period 2025-12-31 | 0000318154-26-000010 |
| 2026-02-03 | 16:03 ET | [8-K](/filings/0000318154-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-26-000003 |
| 2026-01-30 | 08:00 ET | [8-K](/filings/0001193125-26-030518.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-030518 |
| 2025-11-05 | 18:59 ET | [10-Q](/filings/0000318154-25-000072.md) | Quarterly report, period 2025-09-30 | 0000318154-25-000072 |
| 2025-11-04 | 16:04 ET | [8-K](/filings/0000318154-25-000070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-25-000070 |
| 2025-08-06 | 19:13 ET | [10-Q](/filings/0000318154-25-000056.md) | Quarterly report, period 2025-06-30 | 0000318154-25-000056 |
| 2025-08-05 | 16:03 ET | [8-K](/filings/0000318154-25-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-25-000054 |
| 2025-05-27 | 18:55 ET | [8-K](/filings/0000950170-25-077233.md) | 5.07 Shareholder vote results | 0000950170-25-077233 |
| 2025-05-02 | 18:54 ET | [10-Q](/filings/0000318154-25-000020.md) | Quarterly report, period 2025-03-31 | 0000318154-25-000020 |
| 2025-05-01 | 16:04 ET | [8-K](/filings/0000318154-25-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-25-000018 |
| 2025-04-09 | 08:30 ET | [DEF 14A](/filings/0000950170-25-052315.md) | Proxy statement, period 2025-05-23 | 0000950170-25-052315 |
| 2025-02-14 | 16:18 ET | [10-K](/filings/0000318154-25-000010.md) | Annual report, period 2024-12-31 | 0000318154-25-000010 |
| 2025-02-04 | 16:05 ET | [8-K](/filings/0000318154-25-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-25-000005 |
| 2024-10-31 | 18:43 ET | [10-Q](/filings/0000318154-24-000044.md) | Quarterly report, period 2024-09-30 | 0000318154-24-000044 |
| 2024-10-30 | 16:06 ET | [8-K](/filings/0000318154-24-000042.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-24-000042 |
| 2024-08-07 | 18:54 ET | [10-Q](/filings/0000318154-24-000035.md) | Quarterly report, period 2024-06-30 | 0000318154-24-000035 |
| 2024-08-06 | 16:05 ET | [8-K](/filings/0000318154-24-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-24-000033 |
| 2024-06-03 | 17:17 ET | [8-K](/filings/0001193125-24-153221.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-24-153221 |
| 2024-05-03 | 19:27 ET | [10-Q](/filings/0000318154-24-000020.md) | Quarterly report, period 2024-03-31 | 0000318154-24-000020 |
| 2024-05-02 | 16:03 ET | [8-K](/filings/0000318154-24-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-24-000018 |
| 2024-04-17 | 16:02 ET | [DEF 14A](/filings/0001193125-24-099062.md) | Proxy statement, period 2024-05-31 | 0001193125-24-099062 |
| 2024-02-14 | 16:23 ET | [10-K](/filings/0000318154-24-000011.md) | Annual report, period 2023-12-31 | 0000318154-24-000011 |
| 2024-02-06 | 16:20 ET | [8-K](/filings/0000318154-24-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-24-000004 |
| 2023-12-14 | 09:16 ET | [8-K](/filings/0001193125-23-295027.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-295027 |
| 2023-10-31 | 16:21 ET | [10-Q](/filings/0000318154-23-000064.md) | Quarterly report, period 2023-09-30 | 0000318154-23-000064 |
| 2023-10-31 | 07:15 ET | [8-K](/filings/0000318154-23-000061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-23-000061 |
| 2023-10-06 | 16:01 ET | [8-K](/filings/0001193125-23-252361.md) | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-252361 |
| 2023-10-05 | 07:43 ET | [8-K](/filings/0001193125-23-251090.md) | 8.01 Other events | 0001193125-23-251090 |
| 2023-09-27 | 07:30 ET | [SC 13D](/filings/0001193125-23-243053.md) | Ownership report, active investor | 0001193125-23-243053 |
| 2023-09-12 | 07:30 ET | [8-K](/filings/0001193125-23-233011.md) | 8.01 Other events | 0001193125-23-233011 |
| 2023-09-05 | 09:12 ET | [8-K](/filings/0001193125-23-228161.md) | 8.01 Other events | 0001193125-23-228161 |
| 2023-09-01 | 09:25 ET | [8-K](/filings/0001193125-23-227040.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-227040 |
| 2023-08-04 | 19:28 ET | [10-Q](/filings/0000318154-23-000053.md) | Quarterly report, period 2023-06-30 | 0000318154-23-000053 |
| 2023-08-04 | 17:48 ET | [8-K](/filings/0001193125-23-203033.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-203033 |
| 2023-08-03 | 16:12 ET | [8-K](/filings/0000318154-23-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000318154-23-000049 |
| 2023-06-05 | 08:00 ET | [8-K](/filings/0001193125-23-160316.md) | 8.01 Other events | 0001193125-23-160316 |
| 2023-05-22 | 17:23 ET | [8-K](/filings/0001193125-23-150659.md) | 5.07 Shareholder vote results | 0001193125-23-150659 |
| 2023-05-18 | 08:29 ET | [8-K](/filings/0001193125-23-147662.md) | 8.01 Other events | 0001193125-23-147662 |
| 2023-05-16 | 17:28 ET | [8-K](/filings/0001193125-23-146219.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-146219 |

Page 1 of 7. [Older](/companies/amgn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 19:36 ET. No prices; not investment advice.